0 Комментарии
0 Поделились
811 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
- ИССЛЕДОВАТЬ
-
-
-
-
-
-
-
-
-
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Experts Warn of Disease Gaps While Ivermectin Gains BuzzAs public health experts raise alarms over critical gaps in disease preparedness, Ivermectin has emerged at the center of national healthcare debates. With concerns about the CDC’s capacity to manage outbreaks, questions around public trust, and the balance between prevention and treatment, the drug has regained visibility in policy discussions and research priorities. The...0 Комментарии 0 Поделились 14 Просмотры 0 предпросмотр
-
Why Are American Patients Choosing Ivermectin Over Paxlovid in 2025?In 2025, the landscape of COVID-19 treatment options in the United States continues to evolve. While Paxlovid has been widely prescribed since its emergency authorization, a significant number of American patients are increasingly choosing Ivermectin for COVID-19 instead. This shift in preference is driven by various factors including perceptions of safety, cost considerations,...0 Комментарии 0 Поделились 973 Просмотры 0 предпросмотр